Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging of COX-1 and COX-2 in Multiple Sclerosis
NCT05062083Phase 2Terminated
- Sponsor
- National Institute of Mental Health
- Start
- Jun 2022
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by National Institute of Mental Health. Primary endpoints: Standard Uptake Value Ratio (SUVR) of Lesions With Injection of [11C]PS13, Standard Uptake Value Ratio (SUVR) of Lesions With Injection of [11C]MC1 and 2 more. Started Jun 2022; status: terminated.
Beyond the preview
Go deeper on NCT05062083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05062083.